--- title: "Promising Pharmaceutical Stocks To Watch Now - August 31st" type: "News" locale: "en" url: "https://longbridge.com/en/news/297549568.md" description: "MarketBeat's stock screener identifies Eli Lilly, Pfizer, Johnson & Johnson, Abbott Laboratories, and Merck as top pharmaceutical stocks to watch on August 31st. These companies were selected based on having the highest dollar trading volume recently. The report highlights their involvement in drug development and sales, noting potential growth from approvals but also risks like clinical trials and regulatory decisions." datetime: "2026-08-31T18:02:07.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/297549568.md) - [en](https://longbridge.com/en/news/297549568.md) - [zh-HK](https://longbridge.com/zh-HK/news/297549568.md) generator: "portal-rs" --- # Promising Pharmaceutical Stocks To Watch Now - August 31st - 2 Biotech Stocks Shaping Up for Major Breakouts Eli Lilly and Company, Pfizer, Johnson & Johnson, Abbott Laboratories, and Merck & Co., Inc. are the five Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool. Pharmaceutical stocks are shares of publicly traded companies involved in researching, developing, manufacturing, or selling prescription and over-the-counter medicines. For stock market investors, these stocks can offer growth potential from successful drug approvals and strong sales, but they may also carry significant risks related to clinical-trial results, regulatory decisions, patent expirations, and competition. These companies had the highest dollar trading volume of any Pharmaceutical stocks within the last several days. Get **Eli Lilly and Company** alerts: ## Eli Lilly and Company (LLY) Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. - The FTC Is Suing Hims & Hers Health—Here's Why Investors Shouldn't Panic Read Our Latest Research Report on LLY ## Pfizer (PFE) Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. - As Employers Drop Obesity Drug Coverage, Hims & Hers Could Be the Winner Read Our Latest Research Report on PFE ## Johnson & Johnson (JNJ) Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. Read Our Latest Research Report on JNJ ## Abbott Laboratories (ABT) Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. Read Our Latest Research Report on ABT ## Merck & Co., Inc. (MRK) Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. Read Our Latest Research Report on MRK ## Further Reading - MarketBeat's Top Five Stocks to Own in August 2026 - Dollar General and Dollar Tree Are Recovering, But Not for the Same Reason - AST SpaceMobile Is Down 54%—Can FCC Progress and BlueBirds Reverse the Slide? - Don't Miss These 3 Companies Delivering Strong Guidance Updates - Insider Confidence Is Building in These 3 Very Different Stocks - The SaaSpocalypse Trade Is Cracking, and These 5 Stocks Are Leading Higher *This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.* Continue following MarketBeat Add MarketBeat as your preferred source on Google to see our latest stories in your feed. Add As Preferred Source ## Should You Invest $1,000 in Eli Lilly and Company Right Now? Before you consider Eli Lilly and Company, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Eli Lilly and Company wasn't on the list. While Eli Lilly and Company currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys. View The Five Stocks Here ### Related Stocks - [LLY.US](https://longbridge.com/en/quote/LLY.US.md) - [PFE.US](https://longbridge.com/en/quote/PFE.US.md) - [MRK.US](https://longbridge.com/en/quote/MRK.US.md) - [JNJ.US](https://longbridge.com/en/quote/JNJ.US.md) - [ABT.US](https://longbridge.com/en/quote/ABT.US.md) - [ELIL.US](https://longbridge.com/en/quote/ELIL.US.md) - [LLYX.US](https://longbridge.com/en/quote/LLYX.US.md) - [LLYZ.US](https://longbridge.com/en/quote/LLYZ.US.md) - [ELIS.US](https://longbridge.com/en/quote/ELIS.US.md) - [HIMS.US](https://longbridge.com/en/quote/HIMS.US.md) - [DG.US](https://longbridge.com/en/quote/DG.US.md) - [DLTR.US](https://longbridge.com/en/quote/DLTR.US.md) - [ASTS.US](https://longbridge.com/en/quote/ASTS.US.md) ## Related News & Research - [Pharmaceutical Stocks To Add to Your Watchlist - September 5th](https://longbridge.com/en/news/298116055.md) - [Eli Lilly Is Acquiring Merdia Biosciences for Up to $2.88 Billion. Here's What That Means for Investors.](https://longbridge.com/en/news/297565544.md) - [Merck (MRK), Why Is Its Latest Update Raising Bigger Questions?](https://longbridge.com/en/news/298090109.md) - [Aspen sees Mounjaro Africa sales above $124 million in 2027](https://longbridge.com/en/news/297915112.md) - [Johnson & Johnson (JNJ) Could Be 24% Below Fair Value On FDA Approval News](https://longbridge.com/en/news/297955671.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**